MB-CV-021

N/A

Report date: 2025/01/26 19:09:31

Base Information

Drug NameMB-CV-021
Drug Alias Namepeptide vaccine (MBD)cancer vaccine (MBD)MB-CV-021
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMBD Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMBD Co Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A